Gastrointestinal Endoscopy-Associated Infections: Update on an Emerging Issue
- PMID: 35262904
- DOI: 10.1007/s10620-022-07441-8
Gastrointestinal Endoscopy-Associated Infections: Update on an Emerging Issue
Erratum in
-
Correction to: Gastrointestinal Endoscopy‑Associated Infections: Update on an Emerging Issue.Dig Dis Sci. 2022 Jun;67(6):2691. doi: 10.1007/s10620-022-07502-y. Dig Dis Sci. 2022. PMID: 35378682 No abstract available.
Abstract
Over 17.7 million gastrointestinal (GI) endoscopic procedures are performed annually, contributing to 68% of all endoscopic procedures in the United States. Usually, endoscopic procedures are low risk, but adverse events may occur, including cardiopulmonary complications, bleeding, perforation, pancreatitis, cholangitis, and infection. Infections after the GI endoscopies most commonly result from the patient's endogenous gut flora. Although many studies have reported infection after GI endoscopic procedures, a true estimate of the incidence rate of post-endoscopy infection is lacking. In addition, the infection profile and causative organisms have evolved over time. In recent times, multi-drug-resistant microorganisms have emerged as a cause of outbreaks of endoscope-associated infections (EAI). In addition, lapses in endoscope reprocessing have been reported, with some but not all outbreaks in recent times. This systematic review summarizes the demographical, clinical, and management data of EAI events reported in the literature. A total of 117 articles were included in the systematic review, with the majority reported from North America and Western Europe. The composite infection rate was calculated to be 0.2% following GI endoscopic procedures, 0.8% following ERCP, 0.123% following non-ERCP upper GI endoscopic procedures, and 0.073% following lower GI endoscopic procedures. Pseudomonas aeruginosa was the most common culprit organism, followed by other Enterobacteriaceae groups of organisms and Gram-positive cocci. We have also elaborated different prevention methods such as antimicrobial prophylaxis, adequate sterilization methods for reprocessing endoscopes, periodic surveillance, and current evidence supporting their utilization. Finally, we discuss disposable endoscopes, which could be an alternative to reprocessing to minimize the chances of EAIs with their effects on the environmental and financial situation.
Keywords: Antibiotic prophyalxis; Contamination; Duodenoscopy; Endoscopic retrograde cholangiopancreatography; Endoscopy, colonoscopy; Esophagogastroduodenoscopy; Infection; Infections; Transmission.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Comment in
-
Gastrointestinal Endoscopy‑Associated Infections: We Need to Be Specific.Dig Dis Sci. 2022 Aug;67(8):4261-4262. doi: 10.1007/s10620-022-07584-8. Epub 2022 Jun 15. Dig Dis Sci. 2022. PMID: 35704256 No abstract available.
References
-
- Sivak MV. Gastrointestinal endoscopy: past and future. Gut. 2005;55:1061–1064. - DOI
-
- Digestive Health Network Inc. 2015. Available at: https://aspe.hhs.gov/sites/default/files/private/pdf/255906/DHNAdditiona... . Accessed April 01,2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
